Kinetikos Revenue and Competitors
Estimated Revenue & Valuation
- Kinetikos's estimated annual revenue is currently $5M per year.
- Kinetikos's estimated revenue per employee is $251,000
Employee Data
- Kinetikos has 20 Employees.
- Kinetikos grew their employee count by -9% last year.
Kinetikos's People
| Name | Title | Email/Phone |
|---|---|---|
1 | Co-Founder, CEO | Reveal Email/Phone |
2 | Executive Assistant | Reveal Email/Phone |
Kinetikos Competitors & AlternativesAdd Company
| Competitor Name | Revenue | Number of Employees | Employee Growth | Total Funding | Valuation |
|---|---|---|---|---|---|
#1 | $5M | 40 | -18% | $10M | N/A |
#2 | $24.8M | 99 | 29% | N/A | N/A |
#3 | $84.1M | 0 | N/A | $1.2M | N/A |
#4 | $35.6M | 142 | 30% | N/A | N/A |
#5 | $57.5M | 229 | 6% | N/A | N/A |
#6 | $52.7M | 168 | 25% | $129.6M | N/A |
#7 | $21.1M | 84 | -3% | N/A | N/A |
#8 | $61.2M | 244 | -13% | N/A | N/A |
#9 | $60.6M | 193 | 20% | $115.5M | N/A |
#10 | $56.2M | 179 | -3% | $122.9M | N/A |
What Is Kinetikos?
Kinetikos has developed a solution that combines a medical-grade platform with a mobile app - PDtraKer - for continuous patient-centered care in Parkinson's disease. We instantly translate patients´ movement data into clinical insight for accurate assessment and treatment monitoring, while improving quality of life through continuum care. We currently support clinical care, clinical trials and insurers in Europe and America with the use of our Telehealth tool.
keywords:N/A
N/A
Total Funding
20
Number of Employees
$5M
Revenue (est)
-9%
Employee Growth %
N/A
Valuation
N/A
Accelerator
Kinetikos News
Permaclub w/ Arabian Panther, Fatal Walima, Shefox, Dj Reïne / Ensemble Kinêtikos et Baexs L'Alimentation Générale, 22 avril 2022, Paris. Le...
Profitez de l'agenda pour annoncer vos dates lives web ! Permaclub - w/ Arabian Panther, Fatal Walima, Shefox, Dj Reïne / Ensemble Kinêtikos et Baexs.
Other Companies in Coimbra
| Company Name | Revenue | Number of Employees | Employee Growth | Total Funding |
|---|---|---|---|---|
#1 | N/A | 29 | 93% | N/A |
#2 | $3.7M | 32 | 7% | N/A |
#3 | N/A | 34 | 36% | N/A |
#4 | $3.9M | 34 | 31% | N/A |
#5 | N/A | 42 | -14% | N/A |